The government’s top vaccine official working under Health Secretary Robert F. Kennedy Jr. recently restricted the approval of two COVID-19 vaccines, disregarding recommendations from government ...

Earlier this summer the FDA asked Moderna for more efficacy data on its flu vaccine before it could review an mRNA-based ...

Last fall, people across the United States received a COVID-19 vaccine and a flu shot at the same time. As of June 27, 2024, the Centers for Disease Control and Prevention (CDC) assures that it i ...

Vaccine advisers to the US Food and Drug Administration decided Tuesday that authorizing Novavax’s Covid-19 vaccine – which uses different technology from the three vaccines currently in use ...

Unlike some other Covid-19 shots, Novavax’s vaccine can be stored in standard refrigeration. About 1 in 3 Americans has still not been vaccinated against Covid-19 , more than 100 million people.

The vaccine, which was supported by $1.8 billion in taxpayer funding, uses a more traditional approach than some other COVID-19 vaccines allowed in the USA.

During this time, the Vaccine Adverse Event Reporting System received 6,490 reports of death (0.0019%) among people who received a COVID-19 vaccine. The FDA requires healthcare providers to report ...

FDA Authorizes COVID-19 Vaccine For Emergency Use In U.S. December 11, 2020 9:36 PM ET. Colin Dwyer Enlarge this image. An example of a vial that will carry the COVID-19 vaccine produced by Pfizer ...

The FDA has authorized Pfizer's Covid-19 vaccine for emergency use. Doctors could start receiving shots by early next week. Health care workers could start receiving shots early next week.

FDA’s approval of the Pfizer COVID-19 vaccine comes at a key time for Biden, with Americans growing disenchanted with his handling of the pandemic. Aug. 23, 2021 ...

The FDA's Vaccines and Related Biological Products Advisory Committee voted Tuesday to authorize use of Pfizer-BioNTech's COVID-19 vaccine in children ages 5-11.

The Food and Drug Administration also gave an OK to boosters that differ from the vaccine originally used to immunize people against COVID-19. A mix-and-match approach could ease the booster rollout.